<p>Pooled sera (<b>A</b>) or sera from individual mice (<b>B</b>) vaccinated by different immunization schemes with either mammalian cell- or baculovirus-derived VLPs, were tested for binding to purified PR8 virus or recombinant PR8 HA, respectively.</p
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</...
<p>(a-g) Mice were immunized once i.d. with 25 µg DNA/EP as indicated (n = 6/group), and assayed for...
<p>Each group (8 mice per group) was immunized three times at 2-week intervals with AcHERV-HPL1s (Ac...
<p>BALB/c mice were divided into 3 groups and immunized twice s.c. with 0.1 μg PR8 vaccine or s.l. w...
<p>Mice were vaccinated once with mammalian cell-, or baculovirus- derived VLPs containing 50 ng of ...
<p>(A) Regimen of prime and boost vaccination was followed by viral challenge. IM0, IM1, and IM2 rep...
<p>Mice were immunized subcutaneously with proteins or viruses as indicated (homologous or heterolog...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> or 1×10<sup>8</sup>...
<p>On the indicated days, 11 groups of mice (n = 16 per group) were vaccinated with rHA and challeng...
<p>Pooled sera from animals vaccinated with either mammalian cell- or baculovirus-derived VLPs were ...
<p><sup>a</sup>Sera of six mice from each group were collected at different time points after vaccin...
<p>Shown is the reactivity of sera from mice immunized with mixed L2 PP7 VLPs to L2 peptides. Mice w...
<p>A. Body weight loss in vaccinated/challenged C57/B6 mice. Mice were vaccinated with Pol1, Pol2, A...
<p>Groups of mice were immunized subcutaneously, twice, as indicated, with 4-week intervals. Three m...
<p>IgG antibodies in C57BL/6 mice vaccinated twice with pDNA encoding the nine Pks synthase domains ...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</...
<p>(a-g) Mice were immunized once i.d. with 25 µg DNA/EP as indicated (n = 6/group), and assayed for...
<p>Each group (8 mice per group) was immunized three times at 2-week intervals with AcHERV-HPL1s (Ac...
<p>BALB/c mice were divided into 3 groups and immunized twice s.c. with 0.1 μg PR8 vaccine or s.l. w...
<p>Mice were vaccinated once with mammalian cell-, or baculovirus- derived VLPs containing 50 ng of ...
<p>(A) Regimen of prime and boost vaccination was followed by viral challenge. IM0, IM1, and IM2 rep...
<p>Mice were immunized subcutaneously with proteins or viruses as indicated (homologous or heterolog...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> or 1×10<sup>8</sup>...
<p>On the indicated days, 11 groups of mice (n = 16 per group) were vaccinated with rHA and challeng...
<p>Pooled sera from animals vaccinated with either mammalian cell- or baculovirus-derived VLPs were ...
<p><sup>a</sup>Sera of six mice from each group were collected at different time points after vaccin...
<p>Shown is the reactivity of sera from mice immunized with mixed L2 PP7 VLPs to L2 peptides. Mice w...
<p>A. Body weight loss in vaccinated/challenged C57/B6 mice. Mice were vaccinated with Pol1, Pol2, A...
<p>Groups of mice were immunized subcutaneously, twice, as indicated, with 4-week intervals. Three m...
<p>IgG antibodies in C57BL/6 mice vaccinated twice with pDNA encoding the nine Pks synthase domains ...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</...
<p>(a-g) Mice were immunized once i.d. with 25 µg DNA/EP as indicated (n = 6/group), and assayed for...
<p>Each group (8 mice per group) was immunized three times at 2-week intervals with AcHERV-HPL1s (Ac...